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1. Introduction 
A phospholipid requirement for the activity of 
several membrane-bound enzymes has been clearly 
established, e.g. [1,2] but the evidence for a phos- 
pholipid dependence of mitochondrial NADH dehy- 
drogenase is conflicting at present. Reversible loss of 
NADH-ubiquinone-1 oxidoreductase activity 
following removal of phospholipids by phospholipase 
A treatment [3,4] or cholate and ammonium sulphate 
extraction [5] has been reported, but a water-soluble, 
lipid-free NADH dehydrogenase catalyzing ubi- 
quinone reduction has been isolated by Baugh and 
King [6]. An approach to the study of lipid-protein 
interactions which avoids the potential problem of 
irreversible denaturation  removal of lipids is the 
lipid-substitution technique of Warren et al. [7]. We 
have applied this method to purified NADH-ubi- 
quinone oxidoreductase (Complex I) [8] which is 
isolated as a lipoprotein complex. We are interested 
in investigating the role of lipids in mitochondrial 
electron transport for reasons other than the 
conflicting views on NADH dehydrogenase. Firstly, 
the respiratory chain complexes contain relatively 
high levels of cardiolipin whose specialized function 
(if any) is unknown. Secondly, the means by which 
respiratory complexes interact in the membrane is 
unclear. For example although ubiquinone-lO 
behaves as a kinetically homogeneous pool mediating 
hydrogen transfer from (separate) Complex I to 
Complex III [9], this picture is difficult o reconcile 
with the formation of a 1 : 1 binary complex from 
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these two segments (Complex I-III) [10]. Thirdly, 
since ubiquinone and ubiquinol are so hydrophobic 
the function of phospholipid in the electron transfer 
processes of Complexes I and III may be to provide 
a suitable nvironment for these hydrophobic sub- 
strates rather than to preserve an active conformation 
of the protein. 
2. Materials and methods 
Complex I was purified from bovine heart mito- 
chondria by the method of Hatefi and Rieske [11 ]. 
NADH-ubiquinone-1 oxidoreductase activity at 20°C 
was measured as previously described [5]. Dimyristoyl 
phosphatidylcholine (DMPC) was obtained from 
Koch-Light. Soyabean phosphatidylcholine was 
purified by the method of Ragan and Racker [12]. 
Bovine heart cardiolipin was obtained from Sigma 
Chemical Co. and cardiolipin from Saccharomyces 
cerevisiae was generously given by Drs M. Virji and 
P. Knowles. 
Phospholipid concentrations were determined by 
the phosphate content after digestion with perchloric 
acid [13]. In this context, all concentrations of 
cardiolipin are also expressed as phosphate and 
therefore the true molar concentrations of cardiolipin 
are one-half those indicated. Phospholipid was 
quantitatively extracted from protein and analysed 
by thin-layer chromatography on silica gel as described 
by Rouser and Fleischer [14]. The solvent system used 
was CHCla/methanol/H20 (65/25/4, by vol.). Fatty 
acid composition of lipids was determined by gas 
chromatography of the methyl esters prepared by 
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transesterification. Separation was achieved on a 10% 
DEGS column at 180°C. 
3. Results and discussion 
In the experiment of fig.l, Complex I was incubated 
with various concentrations of cholate or soyabean 
phosphatidylcholine and precipitated with ammonium 
sulphate to produce samples of the enzyme with 
phospholipid contents lower or higher respectively 
than the native enzyme. Complex I as isolated could 
not be activated by increasing the phospholipid 
content but decreased in activity linearly with 
decreasing phospholipid content. The profile of activity 
versus phospholipid content was similar when NADH-  
ubiquinone-I oxidoreductase was measured without 
a phospholipid supplement in the assay, although 
absolute activities were lower and the dependence 
not linear. This experiment and others (Ragan and 
Heron, unpublished observations) have established 
that stimulation of activity by phospholipid in the 
assay is due to more efficient delivery of the hydro- 
phobic substrate, ubiquinone-1, to its site of reduction, 
and not to reactivation of phospholipid-depleted 
Complex I molecules. It is clear from fig.1 that 
Complex I as isolated has only just enough phospho- 
lipid associated with it to maintain maximum activity. 
The changes in activity shown in fig.1 could not be 
attributed to inactivation by cholate, since in the 
presence of excess phospholipid, cholate and ammo- 
nium sulphate treatment did not cause loss of activity 
(or loss of phospholipid). There was no effect of lipid 
depletion on NADH-KaFe(CN)6 oxidoreductase and 
rotenone-insensitive NADH-ubiquinone-1 oxido- 
reductase activities. 
The enzyme was completely inactive when the 
phospholipid content had been reduced to approx. 
0.05/amol/mg protein. Further treatment with cholate 
did not decrease this value and thin-layer chromatog- 
raphy established that the residual lipid was almost 
entirely cardiolipin. The cardiolipin content of 
Complex I was determined by assaying spots on thin- 
layer chromatograms for phosphate and found to be 
0.05 pmol/mg protein. 
In experiments of the type shown in table 1, 
Complex I was first treated with DMPC in 30-fold 
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Fig.1. Dependence ofComplex I activity on phospholipid 
content. The phospholipid content of Complex I (0.21-0.23 
tamol/mg protein) was decreased by treating Complex I 
(5 mg protein/ml 0.67 M sucrose/50 mM Tris/HCl, pH 8) at 
4°C with various concentrations ofcholate between 0.1% 
and 2.5% for 30 min followed by precipitation with 46% 
saturated ammonium sulphate. The enzyme was collected by 
centrifugation at100 000 × g for 20 rain at 4°C and redis- 
solved in the original volume of sucrose-Tris buffer. The 
phospholipid content was increased by treating Complex I 
(5 mg protein/ml) with soyabean phosphatidylcholine dis- 
persed by sonieation i  sucrose-Tris buffer at concentrations 
ranging from 1-16 mM for 30 min at 4°C followed by 
ammonium sulphate precipitation as above. Samples were 
assayed for phospholipid phosphorus and for rotenone- 
sensitive NADH-ubiquinone-1 reductase activity in the 
presence (closed symbols) and absence (open symbols) of a 
phospholipid supplement in the assay. Results from four 
separate experiments are shown. 
cholate concentration was 0.35% (w/v). After precipi- 
tation with ammonium sulphate the activity was 
unaffected and the total phospholipid content had 
increased somewhat to around 0.28/arnol/mg protein. 
Analysis of the fatty acid composition of  this phos- 
pholipid revealed that the myristic acid content was 
76%, which was increased to a maximum of 80% after 
a second treatment with DMPC. The maximum extent 
of exchange was reached within 10 min and did not 
increase over a 24 h period. Of the remaining fatty 
acids, linoleic acid (18 : 2) accounted for a further 
12-14%. Linoleic acid comprises 70% of the fatty 
acids of bovine heart cardiolipin, implying that the 
20% of unexchangeable fatty acids were mostly from 
cardiolipin. This was confirmed by thin-layer 
chromatography (fig.2). 
Some exchange of endogenous cardiolipin for 
DMPC could be shown at higher cholate concentra- 
tions, although this was accompanied by loss of activity 
400 
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Fig.2. Thin-layer chromatography of the phospholipids of 
Complex I after exchange with DMPC. Complex I lipids were 
exchanged with DMPC in 0.35% cholate for 1 h as described 
in table 1. A portion of the exchanged nzyme was treated 
with DMPC again under identical conditions. (A) Phospho- 
lipid from 0.5 mg Complex I; (B) 0.13/~mol DMPC; (C) 
phospholipid from 0.45 mg once-exchanged Complex I;
(D) phospholipid from 0.37 mg twice-exchanged Complex I.
Abbreviations: CL, cardiolipin; PEA, phosphatidylethanol- 
amine; PC, phosphatidyleholine. Assignments of spots was 
by comparison with authentic markers. 
even though the DMPC content was unchanged 
(table 1). More successful were attempts to exchange 
the endogenous cardiolipin for exogenous cardiolipin. 
To follow this process, we used yeast cardiolipin whose 
fatty acid composition (42% palmitoleic acid and 56% 
oleic acid) is quite different from bovine heart cardio- 
lipin. In table 1, Complex I which had already been 
exchanged with DMPC in 0.35% cholate to remove 
endogenous palmitoleic (16 : 1) and oleic (18 : 1) 
acids was further treated with yeast cardiolipin or 
DMPC and yeast cardiolipin. The concentrations of 
the two types of cardiolipins were calculated from 
the linoleic, palmitoleic and oleic acid contents. In 
the presence of both DMPC and yeast cardiolipin, 
activity was largely maintained even at high cholate 
concentrations. At low cholate concentrations 
exchange of c ardiolipins was incomplete and the 
incorporation of yeast cardiolipin was considerably 
greater than the loss of endogenous eardiolipin. As 
the cholate concentration was increased, the incorpo- 
ration of yeast cardiolipin more closely matched the 
loss of endogenous cardiolipin, and the extent of 
exchange was close to that expected for equilibration 
of the endogenous cardiolipin with the five-fold 
greater concentration f added cardiolipin. When 
yeast cardiolipin alone was presented at a high cholate 
concentration, most of the DMPC was removed with 
loss of activity. In addition, the incorporation of yeast 
cardiolipin was greater than the loss of endogenous 
cardiolipin showing that more cardiolipin could be 
taken up when the enzyme was deficient in DMPC. 
The results how the presence of two classes of 
lipid-binding sites in Complex I. Phosphatidylethanol- 
amine and phosphatidytcholine bind at one class of 
site. These lipids are readily removed by cholate with 
loss of enzyme activity. Enzyme activity may be 
restored by dialysis with either type of lipid in cholate 
under special conditions [5]. In addition, lipids bound 
at these sites rapidly exchange with DMPC at low 
cholate concentrations but have low affinity for 
cardiolipin (table 1). Cardiolipin binds preferentially 
at the second class of site, and is not removed by 
cholate treatment (fig.l). Exchange with DMPC occurs 
only at high cholate concentrations and with loss of 
activity (table 1). Exchange with added cardiolipin 
takes place more readily (i.e., at lower cholate 
concentrations) and with retention of activity. It is 
clear that appropriate phospholipids bound at both 
classes of sites are required for enzyme activity. 
We have also shown that the phospholipid content 
of Complex I is only just sufficient o maintain 
maximum activity. The physical properties of this 
lipid (Ragan and Heron, unpublished observations) 
suggest that it may form a single shell or 'annulus' 
[15] around the protein of the complex. If this is 
true of other complexes, e.g., Complex III, then when 
Complex I and Complex III interact they may be 
separated by no more than a single layer of phospho- 
lipid molecules, allowing protein-protein i teraction 
to occur. The relative mobility of the two Complexes 
may be very slow or non-existent in which case there 
is no reason why stoicheiometric interaction should 
not occur [10]. Ubiquinone and ubiquinol could 
still act as mobile hydrogen transfer agents through 
the annular lipid around and between the complexes. 
We are currently using complexes of defined lipid 
composition to investigate he importance of ubi- 
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quinone mobil ity in electron transport and to study 
the interaction between'Complexes I and III. 
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